#IPEM2021 interviewed Michael Lindauer from ACP | Allianz Capital Partners on how the company employs a consistent, long-term, and diversified investment strategy. And how this approach paid off during the COVID-19 pandemic, when its portfolio benefitted from global diversification across Europe, Asia, and America. Watch it, comment it & share it, and stay tuned for the next…
Here comes the first TV interview from IPEM2021 Paris Special Edition with Claire Chabrier, Présidente of France Invest, to tackle the main challenges the Private Equity will have to face. Watch it, comment it & share it, and stay tuned for the next ones [IPEM TV STUDIO sponsored by DLA Piper in partnership with Real Deals / The Drawdown] Sponsored by: In Partnership with:…
Dear IPEM friends, We are so close to meeting for the first time in over a year! I hope that you enjoyed a well-deserved summer break and are now preparing to join us in Paris next September 8/9. To date, 863 companies / 301 GPs / 346 LPs totaling 2,292 delegates have confirmed their attendance. This…
The general public did not know much about mRNA vaccines a few months ago; now biotech firms like Moderna, BioNTech or CureVac have almost become household brand-names! We spoke this month with Sander Slootweg, Founder and Managing Partner of Forbion – one of the leading biotech investors in Europe. He told us about the incredible…
This month, IPEM had its monthly rendez-vous with Robin Doumar, Managing Partner and Founder of Park Square Capital, one of the largest players in private debt in Europe. We discussed with Robin the state of the private credit market, how the market rebounded, the opportunities he sees in Europe in the coming months and how…